Protein arginine deiminases (PADs) have recently emerged at the forefront of drug-discovery programs for several human disorders. Despite this, a precise understanding of their functional roles in human biology remains to be fully elucidated. This report highlights a recent development of next-generation activity-based PAD probes that are highly efficient, cell active, and metabolically stable. This discovery should rapidly expedite functional assignments of PAD biology in both normal and diseased cells, thereby leading to the development of PAD-targeted therapeutics in the near future.
Keywords: activity-based probes; autoimmune diseases; post-translational modifications; protein arginine deiminase; protein citrullination.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.